B

Beam Therapeutics

Develops base editing–based precision medicines

Alliance Management Co-op

Corporate StrategyConfirmed live in the last 24 hours
Internship · Winter 2027Cambridge, MA, USA$30 - $37 /hrIn-person

About the Job

Requirements

  • A bachelor's degree (BS/BA) is required, and the candidate must currently be pursuing an MS, MBA, or PhD.
  • Applicants must be enrolled in a degree-granting college or university program and maintain student status throughout the co-op.
  • Basic working knowledge of Microsoft 365 and artificial intelligence is required.
  • The candidate must be highly organized, detail-oriented, and process-driven, with strong problem-solving skills and sound business judgment.
  • The candidate must be able to work independently and effectively within cross-functional teams.
  • The candidate must have excellent written and verbal communication skills and a collaborative approach to stakeholder engagement.
  • The candidate must have a strong interest in science and drug development and be able to learn and apply complex concepts.

Responsibilities

  • Support development of tools that improve day-to-day Alliance Management business-process efficiency by improving and integrating systems to monitor and track compliance with contractual obligations, using artificial intelligence or other approaches.
  • Support development of tools that enable strategic analysis of alliance-management workflows and decision-making processes, using artificial intelligence or other approaches.
  • Assist with monitoring and actions for compliance with contractual obligations for strategic alliances in the alliance portfolio, as needed.
  • Participate in strategic discussions related to management of a dynamic and growing strategic alliance portfolio.

Desired Qualifications

  • Proficiency in Copilot is a plus.

About the Company

Beam Therapeutics

Develops base editing–based precision medicines

Beam Therapeutics uses base editing to develop precision genetic medicines aimed at correcting disease-causing mutations. It focuses on R&D and collaborates with pharmaceutical companies and research institutions to fund and advance therapies, earning revenue through partnerships, licensing, upfront and milestone payments, and royalties. The company targets genetic disorders such as sickle cell disease with the goal of delivering lifelong cures, differentiating itself through its emphasis on durable genetic remedies and a science-driven, values-led culture.

Company size
501-1,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2017

Recently Posted Jobs

Explore more opportunities at Beam Therapeutics

See more jobs